Olomoucine (Standard)
Olomoucine is an ATP competitive inhibitor of CDKs. Olomoucine is a purine (HY-34431) derivative and inhibits CDC2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E (both IC50=7 μM), CDK/p35 kinase (IC50=3 μM) and ERK1/p44 MAP kinase (IC50=25 μM). Olomoucine regulates cell cycle and shows anti-melanin tumor activity.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 101622-51-9
- 分子式: C15H18N6O
- 分子量:298.34
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-W011428
OlomoucineCDK Inhibitor -
HY-16297A
AbemaciclibCDK4/6 Inhibitor -
HY-15339
CVT-313CDK2 Inhibitor -
HY-16297AR
Abemaciclib (Standard)CDK4/6 Inhibitor -
HY-103647
K00546CDK1/CDK2 Inhibitor -
HY-104013
Aminopurvalanol ACyclins/Cdk Inhibitor -
HY-15777
RibociclibCDK4/6 Inhibitor -
HY-12302
KenpaulloneCDK1/GSK-3β Inhibitor -
HY-16297
Abemaciclib methanesulfonateCDK4/6 Inhibitor -
HY-12843
BohemineCDK Inhibitor -
HY-10012
AZD-5438CDK1/2/9 Inhibitor -
HY-103380
NSC 625987CDK4 Inhibitor
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 101622-51-9
-
分子量 298.34
-
分子式 C15H18N6O
-
SMILES
CN1C=NC2=C(NCC3=CC=CC=C3)N=C(NCCO)N=C12
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Vesely, J., Havlicek, J., Strnad, M., et al. Inhibition of cyclin-dependent kinases by purine analogues. European Journal of Biochemistry 224, 771-786 (1994). [Content Brief]
[2]. Abraham, R.T., Acquarone, M., Andersen, A., et al. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biology of the Cell 83(2), 105-120 (1995). [Content Brief]
[3]. Hajdúch M, et al. Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine. Anticancer Drugs. 1997 Nov. 8(10):1007-13. [Content Brief]
[4]. Raynaud FI, et al. Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis. Mol Cancer Ther. 2004 Mar. 3(3):353-62. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Olomoucine (Standard) 関連分類
HY-W011428R 関連分類
Powered by Bioz